JP2021533825A5 - - Google Patents
Info
- Publication number
- JP2021533825A5 JP2021533825A5 JP2021531197A JP2021531197A JP2021533825A5 JP 2021533825 A5 JP2021533825 A5 JP 2021533825A5 JP 2021531197 A JP2021531197 A JP 2021531197A JP 2021531197 A JP2021531197 A JP 2021531197A JP 2021533825 A5 JP2021533825 A5 JP 2021533825A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- pore
- optionally
- fragment
- liposome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1812992.4A GB201812992D0 (en) | 2018-08-09 | 2018-08-09 | Liposomes |
| GB1812992.4 | 2018-08-09 | ||
| PCT/GB2019/052239 WO2020030923A1 (en) | 2018-08-09 | 2019-08-09 | Method for preparing liposomes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021533825A JP2021533825A (ja) | 2021-12-09 |
| JP2021533825A5 true JP2021533825A5 (enExample) | 2022-08-12 |
| JP7687683B2 JP7687683B2 (ja) | 2025-06-03 |
Family
ID=63667012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021531197A Active JP7687683B2 (ja) | 2018-08-09 | 2019-08-09 | リポソームの調製方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12233162B2 (enExample) |
| EP (1) | EP3833330A1 (enExample) |
| JP (1) | JP7687683B2 (enExample) |
| CN (1) | CN113286578A (enExample) |
| AU (1) | AU2019317788B2 (enExample) |
| CA (1) | CA3108864A1 (enExample) |
| GB (1) | GB201812992D0 (enExample) |
| IL (1) | IL280703A (enExample) |
| WO (1) | WO2020030923A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11931458B2 (en) | 2021-01-11 | 2024-03-19 | Babak Ghalili | Exosome systems, products and methods |
| CN114259573B (zh) * | 2022-01-06 | 2023-06-20 | 中国人民解放军军事科学院军事医学研究院 | 一种含有胆碱酯酶重活化剂的脑靶向脂质体及其制备方法和用途 |
| WO2023195976A1 (en) * | 2022-04-05 | 2023-10-12 | Babak Ghalili | Exosome systems, products and methods |
| CN115990270B (zh) * | 2022-07-14 | 2023-08-11 | 郑州大学 | 一种抑制肿瘤干性的纳米载体及其制备方法和应用 |
| CN118806683B (zh) * | 2023-09-26 | 2024-11-22 | 天津医科大学眼科医院 | 一种成体干细胞源的细胞内纳米囊泡在抗衰老和毛囊再生中的应用 |
| CN118272405B (zh) * | 2024-02-28 | 2025-01-07 | 浙江大学杭州国际科创中心 | 一种高效分泌纳米抗体药物的基因工程菌及其应用 |
| WO2025259543A1 (en) * | 2024-06-09 | 2025-12-18 | Mercury Bio, Inc. | Targeted delivery of cas13d and associated guide shrna to silence targeted rnas via yeast extracellular vesicles |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012096926A2 (en) * | 2011-01-10 | 2012-07-19 | President And Fellows Of Harvard College | Method for delivering agents into cells using bacterial toxins |
| US20150079631A1 (en) | 2012-03-16 | 2015-03-19 | The General Hospital Corporation | Microvesicle-mediated delivery of therapeutic molecules |
| GB201311057D0 (en) * | 2013-06-21 | 2013-08-07 | Univ Greenwich | Antisense oligonucleotide compositions |
| WO2015002956A1 (en) | 2013-07-01 | 2015-01-08 | Ohio State Innovation Foundation | Exosome delivery system |
| US20150275229A1 (en) | 2014-03-25 | 2015-10-01 | William Douglas Meadow, JR. | Self-iterating exosomal vector for effective biomolecular transfers |
| WO2016187717A1 (en) | 2015-05-26 | 2016-12-01 | Exerkine Corporation | Exosomes useful for genome editing |
| GB2552473A (en) | 2016-07-21 | 2018-01-31 | Evox Therapeutics Ltd | Surface decoration of extracellular vesicles |
-
2018
- 2018-08-09 GB GBGB1812992.4A patent/GB201812992D0/en not_active Ceased
-
2019
- 2019-08-09 CN CN201980063528.4A patent/CN113286578A/zh active Pending
- 2019-08-09 AU AU2019317788A patent/AU2019317788B2/en active Active
- 2019-08-09 JP JP2021531197A patent/JP7687683B2/ja active Active
- 2019-08-09 WO PCT/GB2019/052239 patent/WO2020030923A1/en not_active Ceased
- 2019-08-09 US US17/266,904 patent/US12233162B2/en active Active
- 2019-08-09 EP EP19755418.1A patent/EP3833330A1/en active Pending
- 2019-08-09 CA CA3108864A patent/CA3108864A1/en active Pending
-
2021
- 2021-02-07 IL IL280703A patent/IL280703A/en unknown
-
2025
- 2025-01-15 US US19/021,759 patent/US20250152513A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6946399B2 (ja) | Ｃ／ＥＢＰα低分子活性化ＲＮＡ | |
| US8734853B2 (en) | HDL particles for delivery of nucleic acids | |
| KR101963885B1 (ko) | 세포투과성이 향상된 펩티드 핵산 복합체 및 이를 포함하는 약학적 조성물 | |
| CN105683377B (zh) | 呼吸疾病相关基因特异性siRNA、含有siRNA的双螺旋寡RNA结构、含有它们的组合物用于预防或治疗呼吸疾病 | |
| US20090012021A1 (en) | Delivery of Sirna by Neutral Lipid Compositions | |
| TW202607139A (zh) | 用於杜顯氏肌肉萎縮症(dmd)之多重外顯子跳躍組合物 | |
| US20070014840A1 (en) | Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription | |
| KR20190096148A (ko) | 엔도좀 탈출능을 갖는 펩티드 핵산 복합체 및 이의 용도 | |
| KR20220104118A (ko) | 핵산 복합체를 함유하는 피부 투과성 전달체 및 이의 용도 | |
| CN104024413B (zh) | 小干扰RNA及其应用和抑制plk1基因表达的方法 | |
| CN114306367B (zh) | 一种含有C/EBPα-saRNA的组合物 | |
| JP7032140B2 (ja) | 嚢胞性線維症の処置のための方法及び医薬組成物 | |
| CN119932107A (zh) | 纤维化髓核细胞靶向性抗FAP scFv工程化外泌体负载SKI mRNA递送系统的制备方法及其应用 | |
| KR102603739B1 (ko) | 암 특이적 핵산 분자 전달용 조성물 및 그 용도 | |
| WO2023048572A1 (en) | Targeted lipid nanoparticle formulations | |
| KR20160023784A (ko) | 안티센스 올리고뉴클레오티드 조성물 | |
| JP2026511324A (ja) | 手術関連線維症治療のための遺伝子編集 | |
| WO2024175775A1 (en) | Use of micrornas in the treatment of lung diseases | |
| WO2025261963A1 (en) | Therapeutic delivery compositions | |
| WO2025162482A1 (zh) | 用于预防和治疗癌症转移的aso及其用途 | |
| Thomas | The Use of Supercharged Coiled-Coil Proteins in Combination with Lipid Carriers For Efficient SiRna Delivery | |
| HK40036027B (en) | Peptide nucleic acid complex having endosomal escape capacity, and use thereof | |
| HK40035624A (en) | Skin-permeating carrier containing nucleic acid complex and use thereof | |
| Fletcher et al. | 470. Enhanced Transposition Activities of Mutant Sleeping Beauty Transposases | |
| BR112016000163B1 (pt) | Estrutura de oligo rna de dupla hélice, nanopartículas, composição farmacêutica e formulação liofilizada |